Sort
53,477 grants matching “addiction”
Integrative genetics of behavior with high throughput technologies
$5,648,001David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA
CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN
$5,609,495Christina Mayer · Advanced Bioscience Laboratories, Inc. · N01 · FY2024 · DA
Integrative genetics of behavior with high throughput technologies
$5,607,530David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA
NIDA Clinical Trials Network: Big South/West Node (CTN-0132 and CTN-0139)
$5,606,566Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2025 · DA
Preclinical Development of Novel Dual OXR/KOR Antagonists for Treatment of Substance Use Disorder
$5,598,515John A Butera · Hager Biosciences, Llc · UF1 · FY2021 · DA
DEVELOPMENT OF A RAPID, NON-ADDICTIVE, INTRANASAL TREATMENT FOR HEADACHE DISORDERS
$5,598,503Olfax, Llc · · FY2025 · Defense Health Agency
Indiana Clinical and Translational Sciences Institute
$5,597,901Sharon M Moe · Indiana University Indianapolis · UL1 · FY2021 · TR
NIDA CTN BS/WN Yr16 S1 CTN0109-0110
$5,593,754Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2020 · DA
A Six-Month, RCT of Probuphine Safety and Efficacy in Opioid Addiction
$5,564,010Katherine Beebe Devarney · Titan Pharmaceuticals, Inc. · RC2 · FY2009 · DA
A Phase 3, Double-Blind Efficacy, Safety and Dose-Response Study of Lofexidine (S
$5,544,365Charles W. Gorodetzky · Us Worldmeds, Llc · U01 · FY2013 · DA
The Healthy Brain and Child Development National Consortium Administrative Core
$5,526,673Christina Chambers · University Of California, San Diego · U24 · FY2025 · DA
Biomedical Informatics Section (BIS)
$5,523,778Jia Ling Lin · National Institute On Drug Abuse · ZIH · FY2022 · DA
Biomedical Informatics Section (BIS)
$5,483,572Massoud Vahabzadeh · National Institute On Drug Abuse · ZIH · FY2021 · DA
Scientific Computing & Informatics Core (SCIC)
$5,462,193Jia Ling Lin · National Institute On Drug Abuse · ZIH · FY2023 · DA
Office of the Clinical Director
$5,447,399Antonello Bonci · National Institute On Drug Abuse · ZID · FY2015 · DA
Indiana Clinical and Translational Sciences Institute
$5,402,523Sharon M Moe · Indiana University Indianapolis · UL1 · FY2022 · TR
Office of the Clinical Director
$5,400,014Karran Phillips · National Institute On Drug Abuse · ZID · FY2017 · DA
R-methadone-TAAP/MPAR: an abuse deterrent methadone prodrug with overdose protection: Pre-Clinical Development and Phase 1 Clinical Trial
$5,389,398Lynn Kirkpatrick · Ensysce Biosciences, Inc. · UG3 · FY2019 · DA
Neuronal connectivity within the mesolimbic system
$5,386,047Marisela Morales · National Institute On Drug Abuse · ZIA · FY2024 · DA
HIV Prevention Trials Network: Network Laboratory
$5,382,404Susan H Eshleman · Johns Hopkins University · UM1 · FY2011 · AI
Development of a Potent and Selective Nav1.8 inhibitor for the Treatment of Acute and Chronic Pain with the Goal of Reducing Opioid Use and Preventing Opioid Use Disorders
$5,341,667John Cureton Hunter · Siteone Therapeutics, Inc. · UG3 · FY2023 · DA
Office of the Clinical Director
$5,334,288Karran Phillips · National Institute On Drug Abuse · ZID · FY2016 · DA
Indiana Clinical and Translational Sciences Institute
$5,307,842Anantha Shekhar · Indiana University Indianapolis · UL1 · FY2018 · TR
PF614-MPAR: clinical development of opioid with oral overdose protection
$5,288,921Lynn Kirkpatrick · Ensysce Biosciences, Inc. · U01 · FY2025 · DA
Integrative genetics of behavior with high throughput technologies
$5,274,705David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA